Showing results (161-170 of 233) with videos related to

Sort By:
Pageof 24
ESMO Open|December 8, 2017
Proxies of quality of life in metastatic colorectal cancer: analyses in the RECOURSE trialEric Van Cutsem, Alfredo Falcone, Rocio Garcia-Carbonero, et al.
European Journal of Cancer (Oxford, England : 1990)|May 20, 2022
Treatments after second progression in metastatic colorectal cancer: A pooled analysis of the TRIBE and TRIBE2 studiesDaniele Rossini, Marco M Germani, Sara Lonardi, et al.
Cancer Treatment Reviews|August 25, 2019
Gastric cancer: Translating novels concepts into clinical practiceMassimiliano Salati, Giulia Orsi, Elisabeth Smyth, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 25, 2024
Tackling challenges in rare diseases: The ISGACA approach on non-pancreatic cancers in the periampullary regionBas A Uijterwijk, Daniël H Lemmers, Alma L Moekotte, et al.
European Journal of Cancer (Oxford, England : 1990)|June 10, 2023
Adverse events during first-line treatments for mCRC: The Toxicity over Time (ToxT) analysis of three randomised trialsAlessandra Boccaccino, Daniele Rossini, Alessandra Raimondi, et al.
Therapeutic Advances in Medical Oncology|July 17, 2023
Updated survival outcomes with ivosidenib in patients with previously treated IDH1-mutated intrahepatic-cholangiocarcinoma: an Italian real-world experienceMargherita Rimini, Valentina Burgio, Lorenzo Antonuzzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2010
Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancerDaniel J Sargent, Silvia Marsoni, Genevieve Monges, et al.
Clinical Colorectal Cancer|March 19, 2022
Prognostic and Predictive Role of Body Mass Index (BMI) in Metastatic Colorectal Cancer (mCRC): A Pooled Analisys of Tribe and Tribe-2 Studies by GONOEmanuela Dell'Aquila, Daniele Rossini, Alessandro Galletti, et al.
Clinical Colorectal Cancer|August 25, 2021
Long Term Survival With Regorafenib: REALITY (Real Life in Italy) Trial - A GISCAD StudyEleonora Lai, Marco Puzzoni, Pina Ziranu, et al.
Oncotarget|September 24, 2015
The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenibLuca Faloppi, Maristella Bianconi, Riccardo Giampieri, et al.
Pageof 24